CLL
Showing 1226 - 1250 of 1,319
Solid Tumor Malignancy, Lymphoid Malignancy (Lymphoma and CLL), Leukemia Trial run by the (SNX-5422 Mesylate Hsp90 inhibitor)
Completed
- Solid Tumor Malignancy
- +3 more
- SNX-5422 Mesylate Hsp90 inhibitor
-
Bethesda, MarylandPfizer Investigational Site
May 15, 2012
Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Stage III Multiple Myeloma Trial in Rochester
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- 17-N-allylamino-17-demethoxygeldanamycin/bortezomib
- sorafenib tosylate
-
Rochester, MinnesotaMayo Clinic
Mar 18, 2013
Lymphoma, Small Lymphocytic, Leukemia, Lymphocytic, Chronic Trial in Durham (cenersen sodium, Rituximab, Cyclophosphamide)
Terminated
- Lymphoma, Small Lymphocytic
- Leukemia, Lymphocytic, Chronic
- cenersen sodium
- +3 more
-
Durham, North CarolinaDuke University Medical Center
Nov 26, 2012
Leukemia, Lymphoproliferative Disorders Trial (Phenethyl Isothiocyanate (PEITC))
Withdrawn
- Leukemia
- Lymphoproliferative Disorders
- Phenethyl Isothiocyanate (PEITC)
- (no location specified)
Apr 12, 2013
Leukemia Trial in Baltimore (autologous tumor cell vaccine, rituximab, cyclophosphamide)
Withdrawn
- Leukemia
- autologous tumor cell vaccine
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 1, 2012
Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Alemtuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Fludarabine
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Feb 17, 2012
Leukemia, Lymphocytic, Chronic Trial in Houston (forodesine HCl (BCX-1777))
Completed
- Leukemia, Lymphocytic, Chronic
- forodesine hydrochloride (BCX-1777)
-
Houston, TexasMD Anderson Cancer Center, University of Texas
Feb 6, 2012
Waldenstrom Macroglobulinemia Trial in Paris (BORTEZOMIB)
Completed
- Waldenstrom Macroglobulinemia
-
Paris, FranceHopital La Pitie Salpetriere
Jan 17, 2013
Chronic Lymphocytic Leukemia (CLL) Trial in Australia, United States (forodesine HCl)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- forodesine HCl
-
Beverly Hills, California
- +10 more
Jan 18, 2012
Severe Combined Immunodeficiency Disease, Severe Primary Immunodeficiency Disorder, Undefined T Cell Deficiency Disorder Trial
Terminated
- Severe Combined Immunodeficiency Disease
- +3 more
- Campath -1H
- +3 more
-
Houston, TexasTexas Children's Hospital
Jun 28, 2013
Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)
Terminated
- Chronic Myelogenous Leukemia
- +4 more
- CD8 Depleted Donor Lymphocyte
-
Houston, TexasUT MD Anderson Cancer Center
Aug 22, 2012
Chronic Lymphocytic Leukemia, Leukemia, Tumors Trial in Tianjin (Bendamustine Hydrochloride Injection, Chlorambucil)
Unknown status
- Chronic Lymphocytic Leukemia
- +2 more
- Bendamustine Hydrochloride Injection
- Chlorambucil
-
Tianjin, ChinaHematologic hospital of Chinese academy of medical sciences
Aug 3, 2012
Chronic Lymphocytic Leukemia Trial in Lexington (Bendamustine, Rituximab)
Withdrawn
- Chronic Lymphocytic Leukemia
-
Lexington, KentuckyUniversity of Kentucky
Jan 10, 2012
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Clofarabine)
Terminated
- Chronic Lymphocytic Leukemia
- Leukemia
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Jul 31, 2012
Chronic Lymphocytic Leukemia Trial in Houston (Campath-1H)
Completed
- Chronic Lymphocytic Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012
Lymphoma, Follicular, Lymphoma, Small Lymphocytic Trial in Houston (autologous human tumor-derived HSPPC-96)
Completed
- Lymphoma, Follicular
- Lymphoma, Small Lymphocytic
- autologous human tumor-derived HSPPC-96
-
Houston, TexasM.D. Anderson Cancer Center
Sep 6, 2012
Leukemia Trial (arsenic trioxide)
Withdrawn
- Leukemia
- arsenic trioxide
- (no location specified)
Oct 5, 2012
Chronic Lymphocytic Leukemia Trial (Influenza Vaccine Trivalent Inactivated (TIV), Pegylated interferon (PEGrIFN-a, Pegasys),
Withdrawn
- Chronic Lymphocytic Leukemia
- Influenza Vaccine Trivalent Inactivated (TIV)
- +2 more
- (no location specified)
Aug 2, 2012
Chronic Lymphocytic Leukemia Trial in China (FFP+HDMP+Rituximab)
Unknown status
- Chronic Lymphocytic Leukemia
-
Hefei, Anhui, China
- +13 more
Aug 19, 2012
Chronic Lymphocytic Leukaemia Trial in United Kingdom (Lenalidomide)
Terminated
- Chronic Lymphocytic Leukaemia
-
Bournemouth, Dorset, United Kingdom
- +8 more
Dec 2, 2011
Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in Atlanta (biological, drug, procedure)
Completed
- Myeloproliferative Disorders
- +6 more
- anti-thymocyte globulin
- +6 more
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Aug 29, 2012